rheumatology & Musculoskeltal

---

NIHR Portfolio Studies - open to recruitment:

BSRBR: Toxicity from Biological Therapy
Principal Investigator: Dawn Collier
​Sponsor: University of Manchester
The BSRBR-RA study tracks the progress of people with rheumatoid arthritis (RA) who have been prescribed biologic (including biosimilar) and other targeted therapies in the UK to monitor the long-term safety of these drugs.
​

---